Schelegle E S, Gershwin L J, Miller L A, Fanucchi M V, Van Winkle L S, Gerriets J P, Walby W F, Omlor A M, Buckpitt A R, Tarkington B K, Wong V J, Joad J P, Pinkerton K B, Wu R, Evans M J, Hyde D M, Plopper C G
Department of Anatomy, Physiology, and Cell Biology, School of Veterinary Medicine, University of California, Davis 95616, USA.
Am J Pathol. 2001 Jan;158(1):333-41. doi: 10.1016/S0002-9440(10)63973-9.
To establish whether allergic asthma could be induced experimentally in a nonhuman primate using a common human allergen, three female rhesus monkeys (Macaca mulatta) were sensitized with house dust mite (Dermatophagoides farinae) allergen (HDMA) by subcutaneous injection, followed by four intranasal sensitizations, and exposure to allergen aerosol 3 hours per day, 3 days per week for up to 13 weeks. Before aerosol challenge, all three monkeys skin-tested positive for HDMA. During aerosol challenge with HDMA, sensitized monkeys exhibited cough and rapid shallow breathing and increased airway resistance, which was reversed by albuterol aerosol treatment. Compared to nonsensitized monkeys, there was a fourfold reduction in the dose of histamine aerosol necessary to produce a 150% increase in airway resistance in sensitized monkeys. After aerosol challenge, serum levels of histamine were elevated in sensitized monkeys. Sensitized monkeys exhibited increased levels of HDMA-specific IgE in serum, numbers of eosinophils and exfoliated cells within lavage, and elevated CD25 expression on circulating CD4(+) lymphocytes. Intrapulmonary bronchi of sensitized monkeys had focal mucus cell hyperplasia, interstitial infiltrates of eosinophils, and thickening of the basement membrane zone. We conclude that a model of allergic asthma can be induced in rhesus monkeys using a protocol consisting of subcutaneous injection, intranasal instillation, and aerosol challenge with HDMA.
为了确定是否可以使用常见的人类过敏原在非人类灵长类动物中通过实验诱导过敏性哮喘,对三只雌性恒河猴(猕猴)进行皮下注射屋尘螨(粉尘螨)过敏原(HDMA)致敏,随后进行四次鼻内致敏,并每天暴露于过敏原气雾剂3小时,每周3天,持续长达13周。在气雾剂激发前,所有三只猴子对HDMA皮肤试验均呈阳性。在用HDMA进行气雾剂激发期间,致敏猴子出现咳嗽、呼吸急促且浅,并伴有气道阻力增加,沙丁胺醇气雾剂治疗可使其逆转。与未致敏的猴子相比,致敏猴子产生气道阻力增加150%所需的组胺气雾剂剂量降低了四倍。气雾剂激发后,致敏猴子血清中的组胺水平升高。致敏猴子血清中HDMA特异性IgE水平升高,灌洗中嗜酸性粒细胞和脱落细胞数量增加,循环CD4(+)淋巴细胞上CD25表达升高。致敏猴子的肺内支气管有局灶性黏液细胞增生、嗜酸性粒细胞间质浸润和基底膜带增厚。我们得出结论,使用由皮下注射、鼻内滴注和HDMA气雾剂激发组成的方案,可以在恒河猴中诱导出过敏性哮喘模型。